Apnimed, Inc.
APMD
IPO
$26.02
-$1.92-6.87%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
8/10/2026
-
The Cerbat Gem
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, June 1, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Beginning of June (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(617) 500-8880
Address
39 John F. Kennedy Street
4th Floor
Cambridge, MA 02138
4th Floor
Cambridge, MA 02138
Country
Year Founded
Business Description
Sector
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global...
more